NLRP3 and acute respiratory distress syndrome: Yin et al. performed in vivo and in vitro experiments to demonstrate that isoflurane acted as a therapeutic approach to improve LPS-induced ALI by inhibiting NLRP3 inflammasome activation in alveolar macrophages [49].